Pancreatic Adenocarcinoma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) HSE (1) | BRCA1 pathogenic variants | Pancreatic Adenocarcinoma | Olaparib | |
| EMA (1) FDA (1) HSE (1) | BRCA2 pathogenic variants | Pancreatic Adenocarcinoma | Olaparib | |
| FDA (1) | v::NRG1 | Pancreatic Adenocarcinoma | Zenocutuzumab |